Resultados de procura - David A. Scheinberg

Limitar resultados
  1. 1
    Actinium-225 in Targeted Alpha-Particle Therapeutic Applications

    Actinium-225 in Targeted Alpha-Particle Therapeutic Applications por David A. Scheinberg, Michael R. McDevitt

    Publicado 2011
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications

    Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications por Matthias Miederer, David A. Scheinberg, Michael R. McDevitt

    Publicado 2008
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Efficient 1-Step Radiolabeling of Monoclonal Antibodies to High Specific Activity with <sup>225</sup>Ac for α-Particle Radioimmunotherapy of Cancer

    Efficient 1-Step Radiolabeling of Monoclonal Antibodies to High Specific Activity with <sup>225</sup>Ac for α-Particle Radioimmunotherapy of Cancer por William F. Maguire, Michael R. McDevitt, Peter Smith‐Jones, David A. Scheinberg

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Chimeric and humanized antibodies with specificity for the CD33 antigen.

    Chimeric and humanized antibodies with specificity for the CD33 antigen. por M S Co, N M Avdalovic, Philip Caron, Mark Avdalovic, David A. Scheinberg, Cary Queen

    Publicado 1992
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Familial Alzheimer Disease Presenilin-1 Mutations Alter the Active Site Conformation of γ-secretase

    Familial Alzheimer Disease Presenilin-1 Mutations Alter the Active Site Conformation of γ-secretase por De-Ming Chau, Christina J. Crump, Jennifer C. Villa, David A. Scheinberg, Yue‐Ming Li

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Carbon nanotubes as vaccine scaffolds

    Carbon nanotubes as vaccine scaffolds por David A. Scheinberg, Michael R. McDevitt, Tao Dao, J. Justin Mulvey, Evan N. Feinberg, Simone Alidori

    Publicado 2013
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  7. 7
    Enhanced Retention of the α-Particle-Emitting Daughters of Actinium-225 by Liposome Carriers

    Enhanced Retention of the α-Particle-Emitting Daughters of Actinium-225 by Liposome Carriers por Stavroula Sofou, Barry J. Kappel, Jaspreet Singh Jaggi, Michael R. McDevitt, David A. Scheinberg, George Sgouros

    Publicado 2007
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Prognostic significance of minimal residual disease detection and PML/RAR-α isoform type: long-term follow-up in acute promyelocytic leukemia

    Prognostic significance of minimal residual disease detection and PML/RAR-α isoform type: long-term follow-up in acute promyelocytic leukemia por Joseph G. Jurcic, Stephen D. Nimer, David A. Scheinberg, Tony DeBlasio, Raymond P. Warrell, Wilson H. Miller

    Publicado 2001
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Renal Tubulointerstitial Changes after Internal Irradiation with α-Particle–Emitting Actinium Daughters

    Renal Tubulointerstitial Changes after Internal Irradiation with α-Particle–Emitting Actinium Daughters por Jaspreet Singh Jaggi, Surya V. Seshan, Michael R. McDevitt, Krista LaPerle, George Sgouros, David A. Scheinberg

    Publicado 2005
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia

    A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia por Kathleen N. S. Cathcart, Javier Pinilla‐Ibarz, Tatyana Korontsvit, Joseph E. Schwartz, Victoriya Zakhaleva, Esperanza B. Papadopoulos, David A. Scheinberg

    Publicado 2003
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics

    Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics por Niloufar Ataie, Jingyi Xiang, Neal Cheng, Elliott J. Brea, Wenjie Lu, David A. Scheinberg, Liu C, Ho Leung Ng

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Vitamin C Antagonizes the Cytotoxic Effects of Antineoplastic Drugs

    Vitamin C Antagonizes the Cytotoxic Effects of Antineoplastic Drugs por Mark Heaney, Jeffrey R. Gardner, Nicos Karasavvas, David W. Golde, David A. Scheinberg, Emily A. Smith, Owen A. O’Connor

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Peptide Epitopes from the Wilms' Tumor 1 Oncoprotein Stimulate CD4+ and CD8+ T Cells That Recognize and Kill Human Malignant Mesothelioma Tumor Cells

    Peptide Epitopes from the Wilms' Tumor 1 Oncoprotein Stimulate CD4+ and CD8+ T Cells That Recognize and Kill Human Malignant Mesothelioma Tumor Cells por Rena J. May, Tao Dao, Javier Pinilla‐Ibarz, Tatyana Korontsvit, Victoriya Zakhaleva, Rong H. Zhang, P. Maslak, David A. Scheinberg

    Publicado 2007
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen

    Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen por Sarwish Rafiq, Terence J. Purdon, Anthony F. Daniyan, Mythili Koneru, Tao Dao, C Liu, David A. Scheinberg, Renier J. Brentjens

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Rejection of immunogenic tumor clones is limited by clonal fraction

    Rejection of immunogenic tumor clones is limited by clonal fraction por Ron S. Gejman, Aaron Y. Chang, Heather F. Jones, Krysta M. DiKun, A. Ari Hakimi, Andrea Schietinger, David A. Scheinberg

    Publicado 2018
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias

    A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias por Leonid Dubrovsky, Dmitry Pankov, Elliott J. Brea, Tao Dao, Andrew Scott, Su Yan, Richard J. O’Reilly, Liu C, David A. Scheinberg

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Opportunities and challenges for TCR mimic antibodies in cancer therapy

    Opportunities and challenges for TCR mimic antibodies in cancer therapy por Aaron Y. Chang, Ron S. Gejman, Elliott J. Brea, Claire Y. Oh, Melissa Mathias, Dmitry Pankov, Emily Casey, Tao Dao, David A. Scheinberg

    Publicado 2016
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  18. 18
    Selective Killing of Tumor Neovasculature Paradoxically Improves Chemotherapy Delivery to Tumors

    Selective Killing of Tumor Neovasculature Paradoxically Improves Chemotherapy Delivery to Tumors por Freddy E. Escorcia, Erik Henke, Michael R. McDevitt, Carlos H. Villa, Peter Smith‐Jones, Ronald G. Blasberg, Robert Benezra, David A. Scheinberg

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody

    Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody por Jazmin Schwartz, Jaspreet Singh Jaggi, Joseph A. O’Donoghue, Shanming Ruan, Michael R. McDevitt, Steven M. Larson, David A. Scheinberg, John L. Humm

    Publicado 2011
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia

    A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia por Prabodhika Mallikaratchy, Alessandro Ruggiero, Jeffrey R. Gardner, Vitaly Kuryavyi, William F. Maguire, Mark Heaney, Michael R. McDevitt, Dinshaw J. Patel, David A. Scheinberg

    Publicado 2010
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: